Skip to main content
. 2017 Feb 28;19(8):1135–1144. doi: 10.1093/neuonc/now282

Fig. 2.

Fig. 2

(A) Percent change in FLAIR volume from baseline by central review. (B) Percent change in contrast-enhancing tumor volume from baseline by central review.